MCC Announces: Early Bird Pricing Ends July 25 for Clinical Trial Risk and Performance Management Summit, Sept. 4-5, 2019, Philadelphia, PA

FALLS CHURCH, Va., July 18, 2019 /PRNewswire-PRWeb/ -- Clinical Trial Risk and Performance Management Summit
**Presented by Metrics Champion Consortium**
Sept. 4-5, 2019 ? Philadelphia, PA
http://www.fdanews.com/ctriskperformancemngmntsummit

Early bird pricing for Clinical Trial Risk and Performance Management Summit ends on Thursday, July 25.

Technology has made it easier to collect and report all manner of clinical trial performance metrics. But in that sea of data, are companies focusing on what will move their organization forward?

Clinical trial leaders in every biopharma company are struggling with these questions. Some are ahead of others, but few have mastered the art of turning metrics into process perfection.

Come to Philadelphia Sept. 4 and 5 for the second Metrics Champion Consortium Summit. This will be an exclusive gathering of the top minds in trial performance metrics, spearheaded by MCC Executive Director Linda Sullivan. The keynote speaker will be Ken Getz, Associate Professor and Director, CSDD, Tufts University and Founder and Board Chair, CISCRP, clinical trials guru, founder of CenterWatch and an MCC partner.

Attendees will be able to choose from two new tracks this year: vendor oversight and risk-based quality management. They will benefit from a vendor oversight case study with real-world experts and breakout group discussions on risk management.

Learn from 14 expert speakers how to:

•     Consider the impact of ICH E6(R2) on your data collection and monitoring
•     Use metrics to manage vendor risk and performance
•     Move from your data reports to true action plans
•     Encourage critical thinking skills for risk-based management
•     Look into our crystal ball at what the metrics world will look like in five years

The Clinical Trial Risk and Performance Management Summit is interactive. Attendees roll up their sleeves with speakers and fellow attendees as they tackle case studies that will bring clarity to the metrics process ? and provide needed answers.
Early bird pricing ends on Thursday, July 25.

Who Will Benefit:

This event is designed for professionals from pharmaceutical, biotechnology and medical device companies; CROs; and other clinical service providers who have responsibilities in the following areas:

•     Clinical Operations/Management/ Research/Development
•     Clinical Outsourcing/Vendor Management/Third-Party Management
•     Clinical/Project Operations
•     Performance Analytics/Management/Reporting
•     Metric Reporting/Visualization
•     Quality Management/Clinical Quality Management
•     Compliance/Clinical Compliance/ Regulatory Compliance
•     Monitoring/Site Management/Study Management
•     Clinical Risk Assessment
•     Centralized Monitoring / Risk-based Monitoring
•     Good Clinical Practices
•     Clinical Process Optimization
•     Vendor Oversight

Conference Details
Clinical Trial Risk and Performance Management Summit
**Presented by Metrics Champion Consortium**
Sept. 4-5, 2019 ? Philadelphia, PA
http://www.fdanews.com/ctriskperformancemngmntsummit

Tuition:
Early Bird Pricing: $1,597 (available until July 25, 2019)
Regular Pricing: $1,797 (after July 25, 2019)
Significant team and MCC membership discounts are available.

Easy Ways to Register
Online: http://www.fdanews.com/ctriskperformancemngmntsummit
By phone: 888-838-5578 or 703-538-7600

About MCC
Leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. Founded in 2006, MCC is the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers and sites to improve clinical-trial development through use of MCC standardized performance metrics.

SOURCE MCC